Evidence map›Paper›PMID 11813133›Full record

ArticleAmerican journal of human genetics2002

A polymorphism in the human UGRP1 gene promoter that regulates transcription is associated with an increased risk of asthma.

Tomoaki Niimi, Mitsuru Munakata, Catherine L Keck-Waggoner, Nicholas C Popescu, Roy C Levitt, Michie Hisada, Shioko Kimura

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Association Between Secretoglobin Family 3A Member 2 (SCGB3A2) Gene Polymorphisms and Asthma in a Korean Population.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Role of secretoglobin 3A2 in lung development.American journal of respiratory and critical care medicine · 2008
    Article
  18. Article
  19. Plasma UGRP1 levels associate with promoter G-112A polymorphism and the severity of asthma.Allergology international : official journal of the Japanese Society of Allergology · 2008
    Article
  20. Antenatal risk factors, cytokines and the development of atopic disease in early childhood.Archives of disease in childhood. Fetal and neonatal edition · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Tomoaki NiimiLaboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Mitsuru Munakata
Catherine L Keck-Waggoner
Nicholas C Popescu
Roy C Levitt
Michie Hisada
Shioko Kimura
National Institutes of Health · USFukushima Medical University · JPGenaera (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several traits associated with asthma phenotypes, such as high total serum immunoglobulin E and bronchial hyperresponsiveness, have been linked by numerous genome-screen studies and linkage analyses to markers on human chromosome 5q31-q34. In the present article, we describe UGRP1 (encoding uteroglobin-related protein 1) as one of asthma-susceptibility genes that is located on chromosome 5q31-q32. UGRP1 is a homodimeric secretory protein of 17 kDa and is expressed only in lung and trachea. The G --> A polymorphism was identified at -112 bp in the human UGRP1 gene promoter. The -112A allele is responsible for a 24% reduction in the promoter activity in relation to the -112G allele, as examined by transfection analysis. Electrophoretic mobility-shift analysis revealed that an unknown nuclear factor binds to the region around -112 bp. The binding affinity with the -112A oligonucleotide was reduced by approximately one half, as compared with the -112G oligonucleotide. In a case-control study using 169 Japanese individuals (84 patients with asthma and 85 healthy control individuals), those with a -112A allele (G/A or A/A) were 4.1 times more likely to have asthma than were those with the wild-type allele (G/G).

Indexed as

Carrier ProteinsGene Expression RegulationGenetic Predisposition to DiseaseAllelesAsthmaBase SequenceCase-Control StudiesChromosomes, Human, Pair 5DNADNA-Binding ProteinsElectrophoretic Mobility Shift AssayExonsGene FrequencyHumansImmunoglobulin EIn Situ Hybridization, FluorescenceCarrier ProteinsDNADNA-Binding ProteinsImmunoglobulin ENuclear ProteinsSCGB3A2 protein, humanSecretoglobinsTranscription FactorsUteroglobin

Identifiers

PMID11813133
PMCPMC384948
OpenAlexW1979509255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.